Preclinical Animal Behaviour Market: USD 27.61 Million Growth Forecasted at a CAGR of 5.03% between 2024 to 2028 – Technavio

NEW YORK, Jan. 26, 2024 /PRNewswire/ — The global Preclinical Animal Behaviour Market is set for significant expansion, with a projected growth of USD 27.61 million at an impressive CAGR of 5.03% between 2023 and 2028. The surge in global disease prevalence, including cardiovascular diseases, metabolic disorders, and cancer, is fuelling the demand for innovative therapeutics. This has led to increased preclinical and clinical research activities by pharmaceutical companies and Contract Research Organizations (CROs). Omics-based technologies such as genomics, proteomics, and metabolomics have gained attention, attracting investments for drug development projects. The intense competition in drug development has prompted the need for sophisticated animal behaviour monitoring equipment in preclinical research. For a better understanding of market dynamics and trends, download the free sample report

Regulatory Challenges and Market Segmentation The preclinical animal behaviour market is projected to grow rapidly due to stricter regulations for pharmaceutical safety and increased funding for research in neuroscience, cardiology, metabolic disorders, and oncology.

Technavio has segmented the market into application, end-user, and geography for a comprehensive analysis.

Application: Small Animals and Large AnimalsEnd-Users: Industrial Laboratories and CROs, Academic and Government Research LaboratoriesRegional Analysis: North America is forecasted to contribute 44% to the global market growth during the forecast period.

“The Preclinical Animal Behaviour Market size is driven by the increasing prevalence of chronic diseases, particularly cardiovascular diseases, which demand extensive research.” – Technavio Explore the market contribution of different segments by downloading the Free PDF Sample Report

Preclinical Animal Behavior Market 2024-2028 : Competitive Analysis

We provide a detailed analysis of around 25 vendors operating in the Preclinical Animal Behavior Market, including some of the vendors such as vendors Backed with competitive intelligence and benchmarking, our research reports on the Preclinical Animal Behavior Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Some of the key market players, including ANY-maze, Biobserve GmbH, Columbus Instruments LLC, Conduct Science Inc., Harvard Bioscience Inc., and others, are implementing various strategies such as strategic alliances, partnerships, mergers and acquisitions, and product/service launches.
For a comprehensive overview of the competitive landscape and detailed company analyses, buy the report now.

Preclinical Animal Behavior Market 2024-2028 : Segmentation

Application Small AnimalsLarge AnimalsEnd-user Industrial LaboratoriesCROsAcademicGovernment Research LaboratoriesGeography North AmericaEuropeAsiaRest Of World (ROW)

Learn more about the additional trends impacting the future of the market and the positive and negative consequences on the businesses., download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR45019

Preclinical Animal Behavior Market 2024-2028 : Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our preclinical animal behavior market report covers the following areas:

Preclinical Animal Behavior Market sizePreclinical Animal Behavior Market trendsPreclinical Animal Behavior Market industry analysis

This study identifies Increase in digitization and automation in healthcare sector as one of the prime reasons driving the preclinical animal behavior market growth during the next few years.

Related Reports:

The global preclinical animal telemetry market size is estimated to grow by USD 21.55 million at a CAGR of 5.69% between 2023 and 2028.
The global amino acid analyzer for industrial, preclinical, and clinical usage market size is estimated to grow by USD 33.43 million, at a CAGR of 5.76% between 2023 and 2028.

Table Of Contents :

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Market Segmentation by End-user

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About US

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/preclinical-animal-behaviour-market-usd-27-61-million-growth-forecasted-at-a-cagr-of-5-03-between-2024-to-2028—technavio-302044668.html

SOURCE Technavio